Earnings Call · Q2 FY2026·2026-08-13

Q2 26EPS +39.39%·Rev n/aQ1 26EPS +33.33%·Rev n/aQ4 25EPS +76.05%·Rev n/aQ3 25EPS +30.00%·Rev n/a⚠ consensus missing

Dare Bioscience, Inc. DARE

MarDee Haring-Layton — Chief Accounting Officer

Sabrina Martucci Johnson — President and Chief Executive Officer

−32.1%1d on move date3d−43.9%5d−40.9%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more DARE calls or request research access.

More DARE calls Browse calls Request research access